Incidence of outer retinal tubulation in ranibizumab-treated age-related macular degeneration

Retina

Volumn 35, Issue 6, 2015, Pages 1166-1172

  Dirani, Ali ^a,b   Gianniou, Christina ^a,b   Marchionno, Laetitia ^a,b   Decugis, Doris ^a,b   Mantel, Irmela ^a,b  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b JULES GONIN EYE HOSPITAL   (Switzerland)

Author keywords

age related macular degeneration; incidence; outer retinal tubulation; ranibizumab

Indexed keywords

RANIBIZUMAB; ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

AGE RELATED MACULAR DEGENERATION; AGED; ARTICLE; COHORT ANALYSIS; ENGINEERING; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; OUTER RETINA TUBULATION; RETINA DISEASE; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VISUAL ACUITY; ANTAGONISTS AND INHIBITORS; INCIDENCE; INTRAVITREAL DRUG ADMINISTRATION; PATHOLOGY; PATHOPHYSIOLOGY; PHOTORECEPTOR CELL; PHYSIOLOGY; RETREATMENT; RETROSPECTIVE STUDY; VERY ELDERLY; WET MACULAR DEGENERATION;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INTRAVITREAL INJECTIONS; MALE; PHOTORECEPTOR CELLS, VERTEBRATE; RETREATMENT; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; WET MACULAR DEGENERATION;

EID: 84930481696     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0000000000000439     Document Type: Article

References (19)

1. Zweifel SA, Engelbert M, Laud K, et al. Outer retinal tubulation: a novel optical coherence tomography finding. Arch Ophthalmol 2009;127:1596-1602.
2. Sergouniotis PI, Davidson AE, Lenassi E, et al. Retinal structure, function, and molecular pathologic features in gyrate atrophy.Ophthalmology 2012;119:596-605.
3. Iriyama A, Aihara Y, Yanagi Y. Outer retinal tubulation in inherited retinal degenerative disease. Retina 2013;33:1462-1465.
4. Goldberg NR, Greenberg JP, Laud K, et al. Outer retinal tubulation in degenerative retinal disorders. Retina 2013;33: 1871-1876.
5. Ellabban AA, Hangai M, Yamashiro K, et al. Tomographic fundus features in pseudoxanthoma elasticum: comparison with neovascular age-related macular degeneration in Japanese patients. Eye (Lond) 2012;26:1086-1094.
6. Kojima H, Otani A, Ogino K, et al. Outer retinal circular structures in patients with Bietti crystalline retinopathy. Br J Ophthalmol 2012;96:390-393.
7. Papastefanou VP, Nogueira V, Hay G, et al. Choroidal naevi complicated by choroidal neovascular membrane and outerretinal tubulation. Br J Ophthalmol 2013;97:1014-1019.
8. Panorgias A, Zawadzki RJ, Capps AG, et al. Multimodal assessment of microscopic morphology and retinal functionin patients with geographic atrophy. Invest Ophthalmol Vis Sci 2013;54:4372-4384.
9. Wolff B, Matet A, Vasseur V, et al. En Face OCT imaging for the diagnosis of outer retinal tubulations in age-related macular degeneration. J Ophthalmol 2012;2012:542417.
10. Gupta OP, Shienbaum G, Patel AH, et al. A treat and extend regimen using ranibizumab for neovascular age-related macular degeneration clinical and economic impact. Ophthalmology 2010;117:2134-2140.
11. Faria-Correia F, Barros-Pereira R, Queiros-Mendanha L, et al. Characterization of neovascular age-related macular degeneration patients with outer retinal tubulations. Ophthalmologica 2013;229:147-151.
12. Lee JY, Folgar FA, Maguire MG, et al. Outer retinal tubulationin the comparison of age-related macular degeneration treatments trials (CATT). Ophthalmology 2014.
13. Curcio CA, Medeiros NE, Millican CL. Photoreceptor loss in age-related macular degeneration. Invest Ophthalmol Vis Sci 1996;37:1236-1249.
14. Spaide RF, Curcio CA. Anatomical correlates to the bands seen in the outer retina by optical coherence tomography: literature review and model. Retina 2011;31:1609-1619.
15. CATT Research Group, Martin DF, Maguire MG, et al. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 2011;364:1897-1908.
16. Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group, Martin DF, Maguire MG, et al. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology 2012;119:1388-1398.
17. Busbee BG, Ho AC, Brown DM, et al. Twelve-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration. Ophthalmology 2013;120:1046-1056.
18. Rofagha S, Bhisitkul RB, Boyer DS, et al. Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP). Ophthalmology 2013;120:2292-2299.
19. Jung JJ, Freund KB. Long-term follow-up of outer retinal tubulation documented by eye-tracked and en face spectraldomain optical coherence tomography. Arch Ophthalmol 2012;130:1618-1619.